metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Camrelizumab combined with transcatheter arterial chemoembolization and sorafeni...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Camrelizumab combined with transcatheter arterial chemoembolization and sorafenib or lenvatinib for unresectable hepatocellular carcinoma: A multicenter, retrospective study
Xiumei Jianga,1, Pan Wangb,c,1, Ke Suc,d,1, Han Lic, Hao Chic, Fei Wange, Yu Liua,
Corresponding author
cqmuliuyu@163.com

Corresponding authors.
, Ke Xua,
Corresponding author
nsmcxuke@163.com

Corresponding authors.
a Department of Oncology, Chongqing General Hospital, Chongqing, 401147, China
b Clinical Skills Center, The Affliated Hospital of Southwest Medical University, Luzhou, 646000, China
c Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China
d Department of Radiation Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100000, China
e Department of General Surgery, Luxian People's Hospital, Luzhou, 646100, China
Read
238
Times
was read the article
46
Total PDF
192
Total HTML
Share statistics
Article information
ISSN: 16652681
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 December 38 4 42
2024 November 53 6 59
2024 October 64 18 82
2024 September 37 18 55

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos